Learn About Simply Safe Dividends
[/fusion_text]
These are our most recent articles. Also see which stocks have been this week’s best and worst performers.
Welltower (HCN): A High-Yield Medical REIT Blue Chip
A great way of building long-term wealth is to ride secular mega-trends. One of the largest of these is the aging of America’s population, which is expected to see the population of those of 75 years of age double over the next two decades. Source: Welltower Investor Presentation Thanks to improvements in medical care, people are not just living longer, but consuming more and more medical resources as they age. In fact, as you can see, the amount of annual per capita healthcare spending rises exponentially the older you become. This means that investing in certain companies involved with healthcare can be a great way to profit over time from this major economic shift. One way [...]
What HCP’s Upcoming Spin Off Means For Dividend Investors
HCP Inc. (HCP)’s 30-year dividend growth streak has long made it the darling of high-yield dividend growth investors. HCP is also the only real estate investment trust (REIT) in the S&P Dividend Aristocrats Index. Investors can view analysis on all of the dividend aristocrats here. Source: Simply Safe Dividends However, as covered originally back in March (you can read the original investment thesis here), the company has hit some major rough patches in the last few years. Now management has announced that it will spin off its troubled ManorCare skilled nursing facilities, or SNFs, into a separate REIT, which will greatly change the nature of HCP’s business model going forward. Find out why [...]
Pfizer (PFE): Safe and Steady Dividends
Pfizer (PFE) is a blue-chip dividend stock that has paid a consistent dividend for multiple decades. Furthermore, over the last 20 years the total dividends paid per share has increased at a nearly 10% compound annual growth rate (CAGR). In recent years, however, Pfizer’s total dividend growth rate has slowed and the payout ratio is now over 90%. Should investors be concerned that this global pharmaceutical giant’s best days are behind it or, worse, that another dividend cut could be forthcoming? Let’s start with a look at the business. Business Analysis Pfizer was incorporated in 1942 and today is a global biopharmaceutical company with operations all across the globe. Their portfolio of products includes mainly [...]